ResearcherUniversity of MauritiusNo recent work listed
Archana Bhaw-Luximon
Matched on ORCID iD 0000-0001-6215-6420; OpenAlex author ID A5023321591.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 2, last author 0)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Collaborators
- 3
2015: 1 paper · 2016: 1 paper · 2017: 1 paper
Papers 3
- Mixed poly(vinyl pyrrolidone)-based drug-loaded nanomicelles shows enhanced efficacy against pancreatic cancer cell lines. Co-author DOI 10.1016/j.ejps.2017.03.021↗
- Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification. First author DOI 10.1007/s00432-016-2178-4↗
- New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with nano drug delivery. First author DOI 10.1016/j.canlet.2015.09.007↗
Closest collaborators
The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Dhanjay Jhurry · 3 shared papers, 2015–2017
- Paper Metformin in pancreatic cancer treatment: from clinical trials through basic research to biomarker quantification. DOI 10.1007/s00432-016-2178-4↗
- Paper New avenues for improving pancreatic ductal adenocarcinoma (PDAC) treatment: Selective stroma depletion combined with n… DOI 10.1016/j.canlet.2015.09.007↗
- Paper Mixed poly(vinyl pyrrolidone)-based drug-loaded nanomicelles shows enhanced efficacy against pancreatic cancer cell lin… DOI 10.1016/j.ejps.2017.03.021↗
- Anisha Veeren · 1 shared paper, 2017
- Debabrata Mukhopadhyay · 1 shared paper, 2017
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.